{"nct_id":"NCT02354417","title":"A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies","status":"TERMINATED","status_verified_date":"2018-02","start_date":"2014-12","start_date_type":null,"primary_completion_date":"2016-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["FATE"]}